VIAP

VIA Pharmaceuticals (CE) (VIAP)

VIA Pharmaceuticals Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:VIAP

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2011/06/13	21 : 00	Marketwired	VIA Pharmaceuticals Announces First-in-Human Dosing of VIA-3196 for Treatment of Dyslipidemia	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/03/26	06 : 03	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/03/25	04 : 58	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/02/12	04 : 55	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/19	07 : 09	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 01	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 01	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 01	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2011/01/03	20 : 00	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 14	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 12	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 11	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 10	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 09	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 07	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 07	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 06	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 05	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 01	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	03 : 01	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	02 : 59	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	02 : 59	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	02 : 59	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	02 : 57	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	02 : 57	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
2010/12/31	02 : 55	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)